You are here : Home > Services > Research Process
Process Research and Rapid Supply of APIs

CARBOGEN AMCIS delivers leading process research services that support the drug development process. Early Active Pharmaceutical Ingredient (API) manufacture centers on the rapid synthesis of supplies necessary to perform both toxicology and early-phase clinical trials. Typical batch sizes here range from 50 g to 50 kg and are prepared in the highest standard of Good Manufacturing Practice (cGMP).

Our services are tailored to the individual needs of each client from initial route finding through to cGMP production.

Throughout the process, CARBOGEN AMCIS infuses each stage of our project work with our highly organized, structured approach. Our tried and tested processes translate to a time and cost efficiency that benefits our clients and their projects. When necessary, we integrate our services with the late stage services to deliver a comprehensive service to clients.

CARBOGEN AMCIS has an extensive toolbox including micro-reactor technology and a range of chromatography techniques (SMB, HPLC, MPLC, Biotage). The combination of tools and experienced personnel allows CARBOGEN AMCIS to solve complex chemistry issues and to provide rapid supply of initial API quantities.

The breadth of our equipment available at our sites translates to increased flexibility and capacity to ensure our capability to complete projects on time and on budget.

16 February 2018
CARBOGEN AMCIS Announces a Successful Swissmedic Inspection of its Site in Vionnaz, Switzerland

11 October 2017
CARBOGEN AMCIS Announces a Successful FDA Inspection of its Headquarters Site in Bubendorf, Switzerland

21 July 2017
CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection

DCAT week

World ADC Berlin